People: Sanofi SA (SASY.PA)
Mr. Michel DeWilde, Ph.D., has been Senior Vice President - R&D Sanofi Pasteur and Member of the Global Leadership Team of Sanofi SA since 2001. He is a graduate of the Universite Libre de Bruxellles (ULB). In 1977, he started his career in the vaccine industry as a scientist at what is now GlaxoSmithKline Biologicals. He held various positions and was then named Vice President of R&D in 1993. In 1999, he joined what is now Sanofi Pasteur to head North America R&D and his responsibilities were extended to global vaccine R&D in 2001, overseeing the development and registration of a number of vaccines in the US and globally. He was involved in the acquisition of Acambis and Vaxdesign.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|